Last Updated: June 2026
At Doctala Global, safeguarding sensitive healthcare information is a core part of our commitment to patients, healthcare professionals, and organizations. Our access control framework is designed to ensure that only authorized users can access the information, tools, and services relevant to their role.
Access across the Doctala Global platform is governed through role-based permissions. Each user is assigned access according to their role and responsibilities, ensuring that information remains available only to those who are authorized to view or manage it.
This structured approach helps maintain data privacy while supporting efficient collaboration across the healthcare ecosystem.
All users are required to authenticate their identity before accessing platform services. Secure login procedures help protect accounts from unauthorized access and support the integrity of healthcare information.
Doctala Global follows the principle of least privilege, meaning users are granted only the level of access necessary to perform their intended activities. This approach reduces security risks and helps protect sensitive patient and organizational data.
To maintain a secure environment, access activities may be monitored and logged. This enables the platform to detect unusual behavior, investigate potential security concerns, and support compliance requirements.
Users play an important role in maintaining platform security. Account holders are responsible for:
Access permissions are regularly reviewed and may be updated as user roles, responsibilities, or organizational requirements change. Access can be modified, restricted, or revoked when necessary to protect the security and integrity of the platform.
Doctala Global continuously evaluates and enhances its access control practices to align with evolving security standards, healthcare requirements, and industry best practices. Our goal is to provide a secure, reliable, and trusted environment for healthcare collaboration and communication.
For questions, feedback, or legal concerns, please contact:
